Adverse events204

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 204

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk
other	Diarrhoea	Gastrointestinal disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	146	2,183
other	Diarrhoea	Gastrointestinal disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	75	1,088
other	Nausea	Gastrointestinal disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	89	2,183
other	Nausea	Gastrointestinal disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	67	1,088
other	Injection site erythema	General disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	377	2,183
other	Injection site erythema	General disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	211	1,088
other	Injection site induration	General disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	342	2,183
other	Injection site induration	General disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	110	1,088
other	Injection site nodule	General disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	1,383	2,183
other	Injection site nodule	General disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	427	1,088
other	Injection site pain	General disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	1,231	2,183
other	Injection site pain	General disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	581	1,088
other	Injection site swelling	General disorders	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	149	2,183
other	Injection site swelling	General disorders	Randomized Blinded Phase: Placebo LEN + F/TDF	104	1,088
other	Anal chlamydia infection	Infections and infestations	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	289	2,183
other	Anal chlamydia infection	Infections and infestations	Randomized Blinded Phase: Placebo LEN + F/TDF	128	1,088
other	Anal gonococcal infection	Infections and infestations	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	233	2,183
other	Anal gonococcal infection	Infections and infestations	Randomized Blinded Phase: Placebo LEN + F/TDF	99	1,088
other	Influenza	Infections and infestations	Randomized Blinded Phase: LEN + Placebo-to-match (PTM) F/TDF	120	2,183
other	Influenza	Infections and infestations	Randomized Blinded Phase: Placebo LEN + F/TDF	66	1,088

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04925752/events

API reference For AI assistants

Adverse events204

Sources 3

Read this list from software.